Galera Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing transformative medicines for patients with cancer and fibrosis-related diseases. Their lead product candidate is designed to selectively activate an enzyme that helps protect healthy tissue during radiotherapy and enhance the tumor-killing effects.
Notification